Total Payments
$1,199
2024 Payments
$557.93
Companies
16
Transactions
61
Medicare Patients
4,942
Medicare Billing
$446,763
Payment Breakdown by Category
Food & Beverage$1,163 (96.9%)
Education$36.81 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,163 | 58 | 96.9% |
| Education | $36.81 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $372.43 | 20 | $0 (2024) |
| Amgen Inc. | $146.00 | 7 | $0 (2024) |
| ABBVIE INC. | $139.68 | 7 | $0 (2024) |
| PFIZER INC. | $135.14 | 7 | $0 (2024) |
| Lilly USA, LLC | $88.13 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.78 | 2 | $0 (2023) |
| Abbott Laboratories | $47.61 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $46.07 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $39.58 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $24.28 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $557.93 | 28 | Novo Nordisk Inc ($186.31) |
| 2023 | $444.97 | 20 | ABBVIE INC. ($107.91) |
| 2022 | $14.39 | 1 | IDORSIA PHARMACEUTICALS US INC ($14.39) |
| 2021 | $14.83 | 1 | Amarin Pharma Inc. ($14.83) |
| 2020 | $34.61 | 2 | Novartis Pharmaceuticals Corporation ($17.75) |
| 2019 | $52.75 | 3 | Supernus Pharmaceuticals, Inc. ($22.26) |
| 2018 | $34.96 | 3 | PFIZER INC. ($22.92) |
| 2017 | $45.00 | 3 | Novo Nordisk Inc ($45.00) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Bone Health | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: VACCINES | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Bone Health | ||||||
| 06/04/2024 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Biological | ||||||
| 04/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Inflammation | ||||||
| 04/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Obesity | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Diabetes Care | ||||||
| 04/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Obesity | ||||||
| 02/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Inflammation | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,352 | 1,704 | $315,505 | $130,005 |
| 2022 | 16 | 1,261 | 1,461 | $239,188 | $105,697 |
| 2021 | 19 | 1,313 | 1,594 | $261,610 | $117,763 |
| 2020 | 11 | 1,016 | 1,407 | $229,818 | $93,298 |
Total Patients
4,942
Total Services
6,166
Medicare Billing
$446,763
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 546 | $113,580 | $47,114 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 198 | 198 | $59,400 | $25,122 | 42.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 196 | 196 | $37,240 | $15,640 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 57 | $20,520 | $7,215 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 92 | $13,935 | $5,596 | 40.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $9,810 | $4,785 | 48.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $8,505 | $4,532 | 53.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 191 | 191 | $8,595 | $3,472 | 40.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 22 | 43 | $8,643 | $2,678 | 31.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,940 | $2,256 | 45.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 45 | $4,725 | $2,199 | 46.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $2,520 | $1,899 | 75.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $5,110 | $1,799 | 35.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 18 | 18 | $6,120 | $1,751 | 28.6% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 16 | 16 | $3,056 | $1,104 | 36.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,200 | $723.60 | 60.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $2,100 | $562.80 | 26.8% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 13 | 13 | $1,300 | $522.60 | 40.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 13 | $1,040 | $481.13 | 46.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 32 | $2,368 | $351.23 | 14.8% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 21 | 21 | $798.00 | $200.00 | 25.1% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 13 | 13 | $0.13 | $0.13 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 243 | 412 | $84,460 | $35,283 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 188 | 188 | $50,170 | $24,547 | 48.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 185 | 185 | $35,150 | $15,025 | 42.7% |
About Dr. Thomas Feely, MD
Dr. Thomas Feely, MD is a Internal Medicine healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477722890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Feely, MD has received a total of $1,199 in payments from pharmaceutical and medical device companies, with $557.93 received in 2024. These payments were reported across 61 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,163).
As a Medicare-enrolled provider, Feely has provided services to 4,942 Medicare beneficiaries, totaling 6,166 services with total Medicare billing of $446,763. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Leesburg, VA
- Active Since 02/29/2008
- Last Updated 10/02/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477722890
Products in Payments
- Ozempic (Drug) $240.64
- VRAYLAR (Drug) $97.45
- Otezla (Drug) $92.24
- NURTEC ODT (Drug) $78.15
- MOUNJARO (Drug) $71.22
- TRADJENTA (Drug) $60.78
- Wegovy (Drug) $59.54
- UBRELVY (Drug) $42.23
- EVENITY (Biological) $39.87
- Veozah (Drug) $39.58
- FREESTYLE LIBRE 3 (Device) $28.72
- RECORLEV (Drug) $24.28
- LYRICA (Drug) $22.92
- TROKENDI XR (Drug) $22.26
- PAXLOVID (Drug) $20.20
- FREESTYLE LIBRE 2 (Device) $18.89
- Tresiba (Drug) $18.33
- ENTRESTO (Drug) $17.75
- EMGALITY (Drug) $16.91
- FARXIGA (Drug) $16.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Leesburg
Dr. David Lichtinger, D.o, D.O
Internal Medicine — Payments: $17,918
Internal Medicine $17,918
Jahanbakhsh Naghshin, M.d, M.D
Internal Medicine — Payments: $13,133
Internal Medicine $13,133
Sheyla Zelaya-Aragon
Internal Medicine — Payments: $11,938
Internal Medicine $11,938
Diane Traficante, Do, DO
Internal Medicine — Payments: $9,193
Internal Medicine $9,193
Dr. Ravi Gupta, M.d, M.D
Internal Medicine — Payments: $8,000
Internal Medicine $8,000
Dr. Sepehr Mesdaghinia, M.d, M.D
Internal Medicine — Payments: $6,588
Internal Medicine $6,588